Multicenter phase2 clinical trial of tailored therapy according to MGMT methylation status for elderly glioblastoma patients

Phase 2

Recruiting

• Conditions: Elderly glioblastoma

• Registration Number: JPRN-UMIN000012172
• Lead Sponsor: Saitama Medical University International Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-10-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Not provided

Exclusion Criteria

1) Previous or concurrent cancer within 5 years, excluding carcinoma in situ, skin cancers except melanoma which was curatively treated 2) Infectious disease requiring systemic treatment 3) Psychotic disorder 4) hepatitis B virus carrier

Study & Design

• Study Type: Interventional
• Study Design: Not specified